Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any age, gender, or physical condition level may be considered.
- People who have been diagnosed with pancreatic adenocarcinoma (a specific type of pancreatic cancer), confirmed through laboratory testing of tissue or cell samples.
- People whose cancer has been tested and found to have a specific gene change called a KRAS mutation, and who have already received treatment targeting that mutation.
- People who are able to attend all required study visits according to the trial schedule.
- People who are willing to take part and sign a consent form agreeing to join the study.
Who may not be able to join:
- People whose pancreatic condition is not caused by cancer (for example, non-cancerous pancreatic diseases).
- People whose cancer in the pancreas did not originally start there — meaning the cancer spread to the pancreas from another part of the body.
- People who are unable to attend the required study visits according to the trial schedule.
- People who are not willing to take part or who do not wish to sign the consent form.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Guopei Luo, Fudan University
Phone: 86 21-64175590
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.